Salt Lake City, UT · Founded 2019 · Privately Held (backing)
Developer of an epigenetic medicine platform designed to tackle health issues by overhauling the trial-and-error methodology. Inherent Biosciences is based in Salt Lake City, UT and was founded in 2019. It was valued at $18.1 million at its early-stage round in Sep 2022, the last priced event on record. It has raised $9.8 million across 1 recorded round; the latest was a $1.5 million seed round in Aug 2022.
PMV mark · valuation
$18.1M
Oct 2026
Priced at
its early-stage round
Sep 2022
Total raised
$9.8M
Last round
Seed Round
Aug 2022
Team — not yet on record
No current team members for Inherent Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Inherent Biosciences with a free account
·The complete investor list: 18 names
·Watch Inherent Biosciences: the Monday email on marks, rounds and moves
